KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Moderna (MRNA) Change in Inventory (2020 - 2025)

Historic Change in Inventory for Moderna (MRNA) over the last 6 years, with Q3 2025 value amounting to $91.0 million.

  • Moderna's Change in Inventory rose 72727.27% to $91.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$78.0 million, marking a year-over-year decrease of 129.87%. This contributed to the annual value of -$83.0 million for FY2024, which is 8888.89% up from last year.
  • As of Q3 2025, Moderna's Change in Inventory stood at $91.0 million, which was up 72727.27% from $114.0 million recorded in Q2 2025.
  • Moderna's 5-year Change in Inventory high stood at $501.0 million for Q1 2022, and its period low was -$1.1 billion during Q4 2022.
  • In the last 5 years, Moderna's Change in Inventory had a median value of $91.0 million in 2025 and averaged $15.0 million.
  • Per our database at Business Quant, Moderna's Change in Inventory soared by 91276.6% in 2021 and then plummeted by 33697.48% in 2022.
  • Over the past 5 years, Moderna's Change in Inventory (Quarter) stood at $476.0 million in 2021, then plummeted by 336.97% to -$1.1 billion in 2022, then surged by 74.73% to -$285.0 million in 2023, then fell by 2.11% to -$291.0 million in 2024, then surged by 131.27% to $91.0 million in 2025.
  • Its Change in Inventory was $91.0 million in Q3 2025, compared to $114.0 million in Q2 2025 and $8.0 million in Q1 2025.